SILO PHARMA, INC. Capital Units, Value
SILO PHARMA, INC. (SILO) had Capital Units, Value of $9.91 million as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Notes › Equity
us-gaap:CapitalUnits · last filed 2022-03-28
- 2021-12-31: Capital Units, Value $9.91M.
| Period end | Capital Units, Value |
|---|---|
| 2021-12-31 | $9.91M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |